
Summary:
New clinical trial execution models have been introduced over the last decade, providing local communities with more direct access to clinical research through remote sites, retail pharmacies, mobile units, site staff embedded in clinical care settings, and more.
In this session, recorded at the 2024 CRAACO: Clinical Research as a Care Option conference, Joan Chambers of the Tufts Center for the Study of Drug Development shared preliminary survey results conducted by the Tufts CSDD to help industry understand the strategic and structural growth of new trial sites and partnerships in bringing trials directly to local communities.
This podcast sheds light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.
For more information, go to theconferenceforum.org
In this podcastRelated Podcasts
View All
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness

How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development

Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
